共 50 条
- [41] Four-Year Clinical Outcomes From Randomized Comparison of Everolimus-eluting Bioresorbable Vascular Scaffolds Versus Everolimus-eluting Metallic Stents in Patients With Coronary Artery Disease From ABSORB China Trial [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 72 (13) : B128 - B128
- [42] Comparison of the everolimus-eluting bioresorbable vascular scaffold versus the everolimus-eluting metallic stent in real-world patients with ST-segment elevation myocardial infarction [J]. POSTEPY W KARDIOLOGII INTERWENCYJNEJ, 2020, 16 (01): : 49 - 57